Loading...
XTSEIVQ
Market cap7mUSD
Dec 20, Last price  
0.13USD
1D
8.33%
1Q
-25.71%
IPO
-98.56%
Name

Invesque Inc

Chart & Performance

D1W1MN
XTSE:IVQ chart
P/E
—
P/S
0.04
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
11.40%
Revenues
193m
-2.63%
0534,5881,503,9621,607,2471,474,8524,781,9471,715,1881,644,518873,46339,891,00063,075,000112,379,000144,689,000217,387,000210,450,000198,035,000192,829,000
Net income
-99m
L+136.23%
00000003,367,9861,237,2724,877,00016,263,000-12,275,000-5,359,000-184,004,000-28,537,000-42,010,000-99,240,000
CFO
6m
-49.37%
0000000009,240,00040,814,00024,972,00016,170,00025,090,00018,680,00011,912,0006,031,000
Dividend
Mar 30, 20200.061 USD/sh
Earnings
Mar 13, 2025

Profile

Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.
URL
https://invesque.com/
IPO date
Sep 20, 2019
Employees
1,517
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
192,829
-2.63%
198,035
-5.90%
210,450
-3.19%
Cost of revenue
135,517
135,020
138,486
Unusual Expense (Income)
NOPBT
57,312
63,015
71,964
NOPBT Margin
29.72%
31.82%
34.20%
Operating Taxes
(312)
(1,127)
16,302
Tax Rate
22.65%
NOPAT
57,624
64,142
55,662
Net income
(99,240)
136.23%
(42,010)
47.21%
(28,537)
-84.49%
Dividends
Dividend yield
Proceeds from repurchase of equity
(163)
(10,601)
BB yield
0.87%
15.22%
Debt
Debt current
279,845
444,292
55,349
Long-term debt
308,400
321,165
838,397
Deferred revenue
Other long-term liabilities
372,780
61,394
85,299
Net debt
577,500
688,801
823,937
Cash flow
Cash from operating activities
6,031
11,912
18,680
CAPEX
(5,814)
(6,516)
(7,575)
Cash from investing activities
132,051
137,485
119,188
Cash from financing activities
(154,916)
(141,187)
(152,632)
FCF
(241,012)
106,005
57,016
Balance
Cash
10,745
27,579
19,369
Long term investments
49,077
50,440
Excess cash
1,104
66,754
59,286
Stockholders' equity
134,828
223,304
277,999
Invested Capital
798,628
973,853
1,192,344
ROIC
6.50%
5.92%
4.37%
ROCE
7.17%
6.06%
5.75%
EV
Common stock shares outstanding
56,704
56,635
56,312
Price
0.33
-73.17%
1.23
-52.69%
2.60
14.54%
Market cap
18,712
-73.14%
69,661
-52.42%
146,412
15.80%
EV
682,118
844,062
1,056,031
EBITDA
72,896
79,531
94,116
EV/EBITDA
9.36
10.61
11.22
Interest
58,450
32,964
30,829
Interest/NOPBT
101.99%
52.31%
42.84%